FDA Approved: HALOPERIDOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for HALOPERIDOL LACTATE from Hikma Pharmaceuticals USA Inc., authorizing modifications under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Huntington Disease
• Psychosis
• Schizophrenia
• Tourette Syndrome

Drugs mentioned

• HALOPERIDOL LACTATE (HALOPERIDOL)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL LACTATE)